Evaluating patient satisfaction in joint rheumatologist and dermatologist consultations for psoriatic arthritis
Official title: Evaluation of Patient Satisfaction and Therapeutic Impact Regarding Joint Consultation Rheumatologist/Dermatologist
Run by Centre Hospitalier le Mans · NCT04800289 · Data updated 2026-11-12
This study is trying to see if having both a rheumatologist and a dermatologist work together in appointments makes people with psoriatic arthritis feel more satisfied and helps them manage their condition better.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | Centre Hospitalier le Mans Academic / other |
| Locations | 1 site (Le Mans) |
| Status | Recruiting |
| Started | July 19, 2020 |
| Main results expected | July 31, 2030 |
| Study ends | July 31, 2030 |
| Registry record updated | March 16, 2021 |
| Trial ID | NCT04800289 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients diagnosed with psoriatic arthritis who are attending joint consultations with a rheumatologist and dermatologist at the Le Mans Hospital.
✕Probably not a fit
Patients whose diagnosis of psoriatic arthritis is not confirmed or retained will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess patient satisfaction and the therapeutic impact of joint consultations between rheumatologists and dermatologists for individuals with psoriatic arthritis. By utilizing questionnaires, the study will gather data on patient experiences and the effectiveness of this multidisciplinary approach in managing their condition. The goal is to document how such collaborative care influences patient outcomes and satisfaction levels. This research addresses a gap in understanding the benefits of integrated care for patients with complex conditions like psoriatic arthritis.
Why it matters
Potential benefit: If successful, this study could enhance patient management and satisfaction through improved collaborative care for psoriatic arthritis.
How similar studies have gone: While there is limited documentation on the impact of joint consultations in this specific context, the approach of multidisciplinary care has shown promise in other studies involving complex conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients received in a joint rheumatologist/dermatologist consultation at the Le Mans Hospital Exclusion Criteria: * Diagnosis of psoriatic arthritis not retained
Where it's running
-
Centre Hospitalier Du Mans
Le Mans, France Recruiting
Study contacts
- Study coordinator: Christelle JADEAU
- Email: cjadeau@ch-lemans.fr
- Phone: 02 43 43 43 43
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
HLA B Leader in Psoriatic Arthritis
This study tests whether the HLA B leader gene is more common in people with psoriatic arthritis than in healthy individuals.
-
TaVNS for Psoriatic Arthritis in Adults
This study tests whether non-invasive taVNS can help reduce disease activity and improve pain and quality of life in adults with psoriatic arthritis.
-
TQH3906 capsules for active psoriatic arthritis in adults
This trial tests whether TQH3906 capsules help people with active psoriatic arthritis more than a placebo over 12 weeks.
-
Picankibart for people with active psoriatic arthritis
This trial tests whether subcutaneous picankibart can improve joint and skin symptoms in adults with active psoriatic arthritis who have not had enough benefit from NSAIDs or non-biologic DMARDs.
-
Bimekizumab by IV infusion versus subcutaneous injection for adults with psoriatic arthritis or axial spondyloarthritis
This trial tests whether bimekizumab given by intravenous (IV) infusion behaves the same in the body as the usual subcutaneous injection in adults with psoriatic arthritis or axial spondyloarthritis.
-
Continued daily zasocitinib treatment for adults with psoriatic arthritis
This extension will try daily zasocitinib in adults with psoriatic arthritis who completed a year of earlier treatment to see how well it works and how safe it is over about two years.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.